| 영문 | fibrous dysplasia | 한글 | 섬유형성이상 |
|---|---|---|---|
| 설명 | 국소 발육장애로 뼈의 모든 성분이 나타나나 성숙한 구조로 분화하지는 못하는 병이다. 임상으로 하나의 뼈 혹은 여러개의 뼈를 동시에 침범할 수 있다. 여러뼈 유형은 갈색색소 침착과 내분비 장애를 동반하며 조숙한 성적 발육을 동반한다. 육안소견으로 경계가 뚜렷한 병터로 조직소견으로는 섬유모세포의 증식과 곡선상의 뼈잔기둥으로 구성되어 있는데 뼈잔기둥은 뼈모세포로 덮여있지 않은 무층뼈(woven bone)이다. |
||
| LNP | large neuronal polypeptide |
|---|---|
| NCL | neuronal ceroid-lipofuscinosis; nucleolin |
| SCN1A | sodium channel, neuronal alpha-subunit type 1 |
| FMD | facility medical director; family medical doctor; fibromuscular dysplasia; foot and mouth disease; f... |
| HED | hereditary ectodermal dysplasia; hydrotropic electron-donor; hypohidrotic ectodermal dysplasia; unit... |
| IND | Intestinal Neuronal Dysplasia |
|---|---|
| NID | Neuronal Intestinal Dysplasia |
| DND | Delayed neuronal death |
| INCL | Infantile neuronal ceroid lipofuscinosis |
| JNCL | Juvenile neuronal ceroid lipofuscinosis |
| neuronal intestinal dysplasia | Increased numbers of ganglion cells with myenteric plexus hyperplasia and increased acetylcholinesterase activity in nerves of the mucosa and submucosa. Clinically, neuronal hyperplasia mimics Hirschprung's disease. Similar findings are seen in patients with multiple endocrine neoplasia syndrome, type IIB, and in neurofibromatosis. Synonym: hyperganglionosis, neuronal intestinal dysplasia. (05 Mar 2000) |
|---|
| adrenergic neuronal blocking agent | A drug that prevents the release of norepinephrine from sympathetic nerve terminals; it does not inhibit the responses of the adrenergic receptors to circulating epinephrine, norepinephrine, and other adrenergic amines. (05 Mar 2000) |
|---|---|
| cell adhesion molecules, neuronal | Surface ligands that mediate cell-to-cell adhesion and function in the assembly and interconnection of the vertebrate nervous system. These molecules promote cell adhesion via a homophilic mechanism. These are not to be confused with ncam (neural cell adhesion molecule), now known to be expressed in a variety of tissues and cell types in addition to nervous tissue. (12 Dec 1998) |
| primary neuronal degeneration | <disease> A progressive, neurodegenerative disease characterised by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language. The cause of nerve cell death is unknown but the cells are recognised by the appearance of unusual helical protein filaments in the nerve cells (neurofibrillary tangles) and by degeneration in cortical regions of brain, especially frontal and temporal lobes. Alzheimer's disease is the most common cause of dementia. (22 May 1997) |
| neuronal | <anatomy> Pertaining to a neuron or neurons (= conducting cells of the nervous system). (18 Nov 1997) |
| neuronal ceroid-lipofuscinosis | A heritable lipidosis with cytoplasmic inclusions staining for ceroid and lipofuscin. Clinically the patient has progressive dementia, retinal degeneration, seizures, and myoclonic jerks. It was formerly thought to be related to tay-sachs disease but the biochemical defect is as yet undetermined. Named according to age of onset: jansky-bielschowsky disease, 2-4 years; batten-spielmeyer-vogt disease, 5-11 years; and kufs disease, adult. (12 Dec 1998) |
| neuronal differentiation | Acquisition during development of specific biochemical, physiological and morphological properties by nerve cells. (18 Nov 1997) |
| neuronal guidance | <cell biology> General term for mechanisms that ensure correct projections by nerve cells in developing and regenerating nervous systems. Implies accurate navigation by growth cones, the highly motile tips of growing neuronal processes. See: growth cone collapse. (12 Mar 1998) |
| neuronal hyperplasia | Increased numbers of ganglion cells with myenteric plexus hyperplasia and increased acetylcholinesterase activity in nerves of the mucosa and submucosa. Clinically, neuronal hyperplasia mimics Hirschprung's disease. Similar findings are seen in patients with multiple endocrine neoplasia syndrome, type IIB, and in neurofibromatosis. Synonym: hyperganglionosis, neuronal intestinal dysplasia. (05 Mar 2000) |
| neuronal plasticity | Ability of nerve cells to change their properties for example by sprouting new processes, making new synapses or altering the strength of existing synapses. See: long-term potentiation. (18 Nov 1997) |
| neuronal polarity | Distribution of specific functions to discrete cellular domains: for example axons and dendrites that have different molecular composition, morphology and ultrastructure and perform different functions. (18 Nov 1997) |
| infantile neuronal degeneration | <neurology, paediatrics> Degenerative disorder of infants with widespread neuronal loss in thalamus, cerebellum, pons, and spinal cord, resembling infantile muscular atrophy. (05 Mar 2000) |
| anterior intestinal portal | Anterior intestinal portal; the opening of the foregut into the midgut. See: epigastric fossa. Synonym: anterior intestinal portal. (05 Mar 2000) |
| gas, intestinal | The complaint referred to as intestinal gas is a common one and the discomfort can be quite significant. Everyone has gas and eliminates it by burping or passing it through the rectum. In many instances people think they have too much gas when in reality they have normal amounts. most people produce 1 to 3 pints of intestinal gas in 24 hours and pass gas an average of 14 times a day. It is made up primarily of odourless vapors such as carbon dioxide, oxygen, nitrogen, hydrogen, and in some families, methane. The unpleasant odour is due to bacteria in the large intestine that release small amounts of gases containing sulfur. (12 Dec 1998) |
| vasoactive intestinal contractor | Mouse homologue of endothelin 2. (18 Nov 1997) |
| vasoactive intestinal peptide | <gastroenterology, protein> Peptide of 28 amino acids, originally isolated from porcine intestine, but later found in the central nervous system where it acts as a neuropeptide and is released by specific interneurons. May also affect behaviour of cells of the immune system. Acronym: VIP (05 Jan 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|